Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)
Latest Information Update: 16 Jul 2024
At a glance
- Drugs Carboplatin (Primary) ; Cyclophosphamide (Primary) ; Docetaxel (Primary) ; Doxorubicin (Primary) ; Pertuzumab (Primary) ; Tamoxifen (Primary) ; Trastuzumab (Primary) ; Aromatase inhibitors
- Indications Advanced breast cancer; Early breast cancer; HER2 positive breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jun 2024 Results (n=35) assessing Pathologic examination of specimen after vacuum-assisted biopsy (VAB) in patients with breast cancer presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 14 Jun 2022 Planned End Date changed from 10 Oct 2021 to 10 Dec 2028.
- 14 Jun 2022 Planned primary completion date changed from 10 Oct 2021 to 10 Dec 2027.